Secondary Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): 30 Years Experience From a Single Center

Autor: Nunes, E.C., Funke, V.A.M., Nabhan, S., Vieira, A., Sola, C.B., Ribeiro, L., Loth, G., Setubal, D.C., Bitencourt, M.A., Bonfim, C.M.S., Medeiros, L.A., Oliveira, M.M., Franco, V., Pasquini, R., Zanis Neto, J.
Zdroj: In Biology of Blood and Marrow Transplantation 2011 17(2) Supplement:S240-S241
Databáze: ScienceDirect